Methyl 1-(2-chloroacetamido)cyclopropane-1-carboxylate
Structure Info
- Chemspace ID
- CSSB00010939173 (In-Stock Building Blocks)
- CAS
- 1521601-27-3, 1000160-72-4
- MFCD
- MFCD26675268
- IUPAC Name
- methyl 1-(2-chloroacetamido)cyclopropane-1-carboxylate
- Mol formula
- C7H10ClNO3
- Mol weight
- 192 Da
- Catalog Number(s)
- 288749, A1091190, AG01B7GQ, AKOS022986270, AR01B85Q, AW02306, ArZ-UP192908, ArZ-UP220407, ArZ-UP478161, BBLS00010939173, BBV-108667024, BD01071922, CSC010939173, CSCR01568417578, EN300-311386, ST01B8XI, TX01B8ME, WKC60127, Y3229700, Z1813112323, Z3242311131, ZX-AN087949, ZX-NM198228, ZX-NM236183, ZXC309552, bbls00010939173, m270062____16412930____8147258
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.05
- Heavy atoms count
- 12
- Rotatable bond count
- 4
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.714
- Polar surface area (Å)
- 55
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB00010939173
Items Overall 10 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 209.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 311.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 444.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 702.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 209.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 311.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 444.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 50 mg | 294.80 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 100 mg | 414.70 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 250 mg | 567.60 | |
Description: methyl 1-(2-chloroacetamido)cyclopropane-1-carboxylate; CAS: 1521601-27-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire